At a glance
- Originator Fidia Farmaceutici
- Class Antidementias; Neuroprotectants
- Mechanism of Action Glutamate receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Neurological disorders; Spinal cord injuries
Most Recent Events
- 10 Oct 2003 Discontinued for Neurological disorders in Italy (unspecified route)
- 10 Oct 2003 Discontinued for Spinal cord injuries in Italy (unspecified route)
- 09 Dec 1996 No-Development-Reported for Neurological disorders in Italy (Unknown route)